- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 48.79M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 48.56M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 46.39M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$229K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$86K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.3M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$12.91M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$12.49M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$10.36M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$9.77M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $17.06M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $7.71M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $17.19M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $17.12M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $3.89M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $4.18M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $4.28M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $4.63M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.01 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.02 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.01 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.02 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.83M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $2.41M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $1.23M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $1.27M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$494K |
| Net Income | Q1 2026 · Mar 31, 2025 | −$751K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$139K |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$427K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $3.59M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $4.31M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $1.86M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $1.21M |
| Capex | Q1 2026 · Mar 31, 2025 | $6K |